Home Applications 209091 Application 209091
Type NDA
Sponsor ASTRAZENECA AB Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 QTERN DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE TABLET;ORAL 10MG;EQ 5MG BASE Yes Yes 002 QTERN DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE TABLET;ORAL 5MG;EQ 5MG BASE Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209091-001 QTERN DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE 10MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2017-02-27 N209091-002 QTERN DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE 5MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2019-05-02
Orange Book patents# Current patent rows page 1 of 1 · 28 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209091-001 6515117 2025-10-04 U-493 Drug substance, Drug product 2017-03-22 N209091-001 6515117*PED 2026-04-04 Pediatric extension N209091-001 8501698 2027-06-20 U-1976 Drug product 2017-03-22 N209091-001 8501698 2027-06-20 U-1977 Drug product 2017-03-22 N209091-001 8501698 2027-06-20 U-493 Drug product 2017-03-22 N209091-001 8501698*PED 2027-12-20 Pediatric extension N209091-001 8221786 2028-03-21 Drug product 2017-03-22 N209091-001 8361972 2028-03-21 U-1976 2017-03-22 N209091-001 8361972 2028-03-21 U-1977 2017-03-22 N209091-001 8361972 2028-03-21 U-493 2017-03-22 N209091-001 8716251 2028-03-21 Drug product 2017-03-22 N209091-001 8221786*PED 2028-09-21 Pediatric extension N209091-001 8361972*PED 2028-09-21 Pediatric extension N209091-001 8716251*PED 2028-09-21 Pediatric extension N209091-001 7919598 2029-12-16 Drug substance 2017-03-22 N209091-001 7919598*PED 2030-06-16 Pediatric extension N209091-002 6515117 2025-10-04 U-493 Drug substance, Drug product 2019-05-24 N209091-002 6515117*PED 2026-04-04 Pediatric extension N209091-002 8501698 2027-06-20 U-493 Drug product 2019-05-24 N209091-002 8501698*PED 2027-12-20 Pediatric extension N209091-002 8221786 2028-03-21 Drug product 2019-05-24 N209091-002 8361972 2028-03-21 U-493 2019-05-24 N209091-002 8716251 2028-03-21 Drug product 2019-05-24 N209091-002 8221786*PED 2028-09-21 Pediatric extension N209091-002 8361972*PED 2028-09-21 Pediatric extension N209091-002 8716251*PED 2028-09-21 Pediatric extension N209091-002 7919598 2029-12-16 Drug substance 2019-05-24 N209091-002 7919598*PED 2030-06-16 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N209091-001 QTERN 10MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2017-02-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 QTERN 5MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2019-05-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD 2017-02-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD 2017-02-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD 2017-02-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209091-001 QTERN 10MG;EQ 5MG BASE TABLET / ORAL RLD, RS 2017-02-27 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N209091-002 QTERN 5MG;EQ 5MG BASE TABLET / ORAL RLD 2019-05-02 bb7c543d1eb4…
Observed Orange Book patent history# Patent history page 1 of 25 · 972 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N209091-001 6515117 2025-10-04 U-493 Drug substance, Drug product 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 6515117*PED 2026-04-04 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8501698 2027-06-20 U-1976 Drug product 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8501698 2027-06-20 U-1977 Drug product 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8501698 2027-06-20 U-493 Drug product 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8501698*PED 2027-12-20 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8221786 2028-03-21 Drug product 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8361972 2028-03-21 U-1977 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8361972 2028-03-21 U-1976 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8361972 2028-03-21 U-493 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8716251 2028-03-21 Drug product 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8221786*PED 2028-09-21 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8361972*PED 2028-09-21 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 8716251*PED 2028-09-21 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 7919598 2029-12-16 Drug substance 2017-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-001 7919598*PED 2030-06-16 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 6515117 2025-10-04 U-493 Drug substance, Drug product 2019-05-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 6515117*PED 2026-04-04 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 8501698 2027-06-20 U-493 Drug product 2019-05-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 8501698*PED 2027-12-20 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 8221786 2028-03-21 Drug product 2019-05-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 8361972 2028-03-21 U-493 2019-05-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 8716251 2028-03-21 Drug product 2019-05-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 8221786*PED 2028-09-21 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 8361972*PED 2028-09-21 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 8716251*PED 2028-09-21 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 7919598 2029-12-16 Drug substance 2019-05-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209091-002 7919598*PED 2030-06-16 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209091-001 6515117 2025-10-04 U-493 Drug substance, Drug product 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 6515117*PED 2026-04-04 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8501698 2027-06-20 U-1976 Drug product 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8501698 2027-06-20 U-1977 Drug product 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8501698 2027-06-20 U-493 Drug product 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8501698*PED 2027-12-20 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8221786 2028-03-21 Drug product 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8361972 2028-03-21 U-1977 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8361972 2028-03-21 U-1976 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8361972 2028-03-21 U-493 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8716251 2028-03-21 Drug product 2017-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209091-001 8221786*PED 2028-09-21 Pediatric extension 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 48 observed states.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 18 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0310-6770 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6770 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6770 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6770 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6770 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6770 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6770 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6770 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current 0310-6780 QTERN dapagliflozin and saxagliptin AstraZeneca Pharmaceuticals LP NDA Current